🇺🇸 FDA
Pipeline program

Cenderitide

CDNP-578-02

Phase 2 small_molecule completed

Quick answer

Cenderitide for Heart Failure is a Phase 2 program (small_molecule) at CAPRICOR THERAPEUTICS, INC. with 2 ClinicalTrials.gov record(s).

Program details

Company
CAPRICOR THERAPEUTICS, INC.
Indication
Heart Failure
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials